|
 |
Faculty |
 |
Statement of Need |
 |
Activity Goal |
 |
Learning Objectives |
 |
Financial Support |
 |
Target Audience |
 |
Credit Information |
Work and Wakefulness: Promoting Guideline-Based Care for Shift Work Disorder
neuroscienceCME Multimedia Snack
Premiere Date: Friday, April 12, 2013This activity offers CE credit for:
- Physicians (CME)
- Other
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Tuesday, April 12, 2016
Note: Credit Is No Longer Available
 | Paul P. Doghramji, MD, FAAFP (Moderator) Senior Family Physician, Collegeville Family Practice Medical Director, Health Services Ursinus College Collegeville, PA |
 | Phyllis C. Zee, MD, PhD Director, Center for Circadian and Sleep Medicine Chief of Sleep Medicine in the Department of Neurology Benjamin and Virginia T. Boshes Professor of Neurology Professor of Neurology (Sleep Medicine) Northwestern University Feinberg School of Medicine Chicago, IL |
Roughly one in five workers in the United States does some form of shift work—a term that includes a broad array of nonstandard work schedules including permanent night shift work, rotating shifts, occasional on-call overnight duty, and even schedules that demand an early awakening from nocturnal sleep. Such work schedules put individuals at risk for developing shift work disorder (SWD). Characterized by insomnia and excessive sleepiness, SWD is a circadian rhythm sleep disorder that can occur when a shift worker sleeps at a time that is not in alignment with the internal circadian propensity for sleep and the when the patient has poor tolerance to this misalignment. Importantly, SWD is a disorder for which clinicians can help many shift workers improve their ability to sleep, maintain wakefulness, and possibly decrease other adverse effects of shift work.
This neuroscienceCME Snack will share faculty discussion between a primary care clinician and a nationally recognized expert in SWD regarding evidence-based best practices to effectively identify and treat SWD in the primary care setting.
- Morgenthaler TI, Lee-Chiong T, Alessi C, et al. Practice parameters for the clinical evaluation and treatment of circadian rhythm sleep disorders. An American Academy of Sleep Medicine report. Sleep. 2007;30(11):1445-1459. PMID: 18041479.
To educate primary care clinicians on how to recognize, diagnose, and manage shift work disorder in a manner that is in accordance with recommendations from the American Academy of Sleep Medicine.
Make One Change Statement: This statement is crafted from pertinent quality measures or clinical guidelines as a performance challenge to all participants. The Make One Change Statement for this activity is to improve diagnosis and management of shift work disorder in alignment with care recommendations from the American Academy of Sleep Medicine.
At the end of this CE activity, participants should be able to:
- Increase the rate at which they screen patients for presence of excessive sleepiness.
- Identify the components of an effective strategy for diagnosis and treatment of shift work disorder as recommended in the American Academy of Sleep Medicine guidelines.
- Implement evidence-based treatment plans that incorporate pharmacological and nonpharmacological options as recommended in the American Academy of Sleep Medicine guidelines for patients with shift work disorder.
Supported by an educational grant from Teva Pharmaceuticals.
Physicians and other non-physician health care professionals with an interest in shift work disorder.
CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CME Outfitters, LLC, designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Post-tests, credit request forms, and activity evaluations must be completed online at www.neurosciencecme.com/TST769 (requires free account activation), and participants can print their certificate or statement of credit immediately (80% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit www.neurosciencecme.com/technical.asp.
Disclosure Declaration
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Doghramji has disclosed that he serves on the speakers bureau for Purdue Pharma L.P.; Takeda; and Teva Pharmaceuticals. He serves as a consultant for Merck & Co.; Purdue Pharma L.P.; and Teva Pharmaceuticals.
Dr. Zee has disclosed that she has received grant and research support from Respironics, Inc. She serves as a consultant for Jazz Pharmaceuticals plc; Merck & Co.; Purdue Pharma L.P.; sanofi-aventis U.S.; UCB, Inc.; and Vanda Pharmaceuticals. She is a stockholder of Teva Pharmaceuticals.
Monique Johnson, MD, CCMEP (planning committee) has no disclosures to report.
Tony Graham, MD (peer reviewer) has no disclosures to report.
Joy Bartnett Leffler, MLA, NASW, CSE (planning committee) has no disclosures to report.
Sandra Haas Binford, MAEd (planning committee) has no disclosures to report.
Sharon Tordoff, CCMEP (planning committee) has no disclosures to report.
Unlabeled Use Disclosure
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
CME Outfitters, LLC, the faculty, and Teva Pharmaceuticals do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).
SN-055-041213-15
